Retinal detachment and degeneration in response to subretinal perfluorodecalin in rabbit eyes

  • Lennart Berglin
  • Jianming Ren
  • Peep V. Algvere
Laboratory Investigations


Perfluorocarbon liquids, including perfluorodecalin (PFD), are useful intraoperative tools in complicated vitreoretinal surgery, such as for giant retinal tears, PVR and intraocular foreign bodies. Due to its high specific gravity (1.91 g/cm3) subretinal complications of PFD may occur. The consequences of subretinal PFD were studied in 23 albino rabbits (28 eyes). Using glass micropipettes (outer diameter of tip 100–120 qm), we injected 50–100 μl PFD subretinally via the vitreous space. The same volume of BSS was injected into 18 control eyes. Eyes were monitored by indirect ophthalmoscopy and examined by light and electron microscopy at 1, 2 and 3 days, and 1, 2, 4 and 12 weeks. Progressive retinal detachments with newly formed retinal breaks in the inferior quadrants developed in 26 of 28 eyes. As early as 1 day postoperatively, subretinal PFD induced loss of outer and inner segments. Local retinal necrosis occurred in 4 eyes 5–7 days after surgery. A marked vacuole formation in retinal layers and PFD emulsification were regularly seen. The control eyes healed spontaneously. Toxic, mechanical and barrier effects may have caused the retinal damage. We advocate that all PFD be removed from the eye at surgery.


Emulsification Retinal Detachment Perfluorocarbon High Specific Gravity Albino Rabbit 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Algvere P, Martini B (1986) Experimental intravitreal proliferation and neovascularization in the cynomolgus monkey. Graefe's Arch Clin Exp Ophthalmol 224:69–75Google Scholar
  2. 2.
    Algvere PV, Hallnäs K, Dafgård E, Höög A (1990) Panretinal photocoagulation aggravates experimental proliferative vitreoretinopathy. Graefe's Arch Clin Exp Ophthalmol 228:461–466Google Scholar
  3. 3.
    Berkowitz BA, Wilson CA, Hatcbell DL (1991) Oxygen kinetics in the vitreous substitute perfluorotributylamine: A19F NMR study in vivo. Invest Ophthalmol Vis Sci 32:2382–2387Google Scholar
  4. 4.
    Blinder KJ, Peyman GA, Paris CL, Dailey JP, Alturki W, Liu KR, Gremillion CM Jr, Clark LC Jr (1991) Vitreon, a new perfluorocarbon. Br J Ophthalmol 75:240–244Google Scholar
  5. 5.
    Chang S (1987) Low viscosity liquid fluorochemicals in vitreous surgery. Am J Ophthalmol 103:38–43Google Scholar
  6. 6.
    Chang S, Zimmerman NJ, Iwamoto T, Ortiz R, Faris D (1987) Experimental vitreous replacement with perfluorotributylamine. Am J Ophthalmol 103:29–37Google Scholar
  7. 7.
    Chang S, Ozmert E, Zimmerman NJ (1988) Intraoperative perfluorocarbon liquids in the management of proliferative vitreoretinopathy. Am J Ophthalmol 106:668–674Google Scholar
  8. 8.
    Chang S, Reppucci V, Zimmerman NJ, Heinemann MH, Coleman DJ (1989) Perfluorocarbon liquids in the management of traumatic retinal detachments. Ophthalmology 96:785–792Google Scholar
  9. 9.
    Chang S, Sparrow JR, Iwamoto T, Gershbein A, Ross R, Ortiz R (1991) Experimental studies of tolerance to intravitreal perfluoro-n-octane liquid. Retina 11:367–374Google Scholar
  10. 10.
    DeMarchis J, Chang S, Ortiz R, Brodie S, Noble K (1989) Electrophysiologic evaluation of short-term vitreous replacement by perfluorocarbon liquids. Invest Ophthalmol Vis Sci 30 [Suppl]:102Google Scholar
  11. 11.
    De Queiroz JM Jr, Özler SA, AlfaroDV, Moreira CA Jr, Liggett PE (1991) Histopathologic evaluation of subretinal perfluorocarbon liquids. Invest Ophthalmol Vis Sci 32 [Suppl]: 881Google Scholar
  12. 12.
    Eckardt C (1992) Behandlung komplizierter Netzhautabl6sungen. Intraoperativer Gebrauch von Perfluordecalin. Der Ophthalmologe 89:22–26Google Scholar
  13. 13.
    Eckardt C, Nicolai U, Winter M, Knop E (1991) Experimental intraocular tolerance to liquid perfluorooctane and perfluoropolyether. Retina 11:375–384Google Scholar
  14. 14.
    Glaser BM, Carter JB, Kuppermann BD, Michels RG (1991) Perfluoro-octane in the treatment of giant retinal tears with proliferative vitreoretinopathy. Ophthalmology 98:1613–1621Google Scholar
  15. 15.
    Miyamoto K, Refojo MF, Tolentino FI, Fournier GA, Albert DM (1984) Perfluoroether liquid as a long-term vitreous substitute: An experimental study. Retina 4:264–268Google Scholar
  16. 16.
    Miyamoto K, Refojo MF, Tolentino FI, Fournier GA, Albert DM (1986) Fluorinated oils as experimental vitreous substitutes. Arch Ophthalmol 140:1053–1056Google Scholar
  17. 17.
    Nicolai U, Eckardt C, Kohlhoff M, Wottge HU (1992) Biocompatibility of silicone oil and high density liquids: an immunologic study. German J Ophthalmol 1:180–187Google Scholar
  18. 18.
    Resnick KI, Shapiro MJ, Kim S (1991) Perfluorooctane as an instrument to manipulate intraocular foreign bodies. Invest Ophthalmol Vis Sci 32 [Suppl]: 881Google Scholar
  19. 19.
    Sparrow JR, Ortiz R, MacLeish PR, Chang S (1990) Fibroblast behavior at aqueous interfaces with perfluorocarbon, silicone and fluorosilicone liquids. Invest Ophthalmol Vis Sci 31:638–646Google Scholar
  20. 20.
    Terauchi H, Negi A, Kazama S, Okinami S, Nagata M (1989) Electrophysiological and histological studies of the vitreous replacement with perfluorotributylamine in the rabbit eye. Invest Ophthalmol Vis Sci 30 [Suppl]:102Google Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • Lennart Berglin
    • 1
  • Jianming Ren
    • 1
  • Peep V. Algvere
    • 1
  1. 1.Vitreo-Retinal ServiceKarolinska Institute, St. Erik Eye HospitalStockholmSweden

Personalised recommendations